Genetic mutation raises CRC mortality risk, studies show

11/14/2012 | Healio

Having the genetic BRAF mutation doubles the mortality risk for colorectal cancer patients, according to an analysis of 26 CRC studies. Canadian researchers said the data show that if the BRAF mutation can successfully be inhibited it could improve survival for patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health